Monroe, NJ, United States of America

Ming You


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ming You

Introduction

Ming You is an accomplished inventor based in Monroe, NJ (US). He holds a total of three patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing compounds that can aid in the treatment of various diseases.

Latest Patents

Ming You's latest patents include innovative compounds known as Tetrahydroisoquinoline derivatives. These compounds are recognized for their ability to inhibit diacylglyceride O-acyltransferase 2 (DGAT2). The invention relates to a compound represented by a specific formula and its pharmaceutically acceptable salts. These compounds may be beneficial in treating, preventing, and suppressing diseases mediated by DGAT2, including hepatic steatosis, diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, and cardiorenal diseases such as chronic kidney diseases and heart failure.

Career Highlights

Throughout his career, Ming You has worked with notable companies, including Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Ming You has collaborated with several professionals in his field, including Jason Eugene Imbriglio and Clare London. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Ming You's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…